Skip to main navigation
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us
Aerovate Therapeutics

SEC Filing Details

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us

SEC Filing Details

Document Details

Form
8-K
Filing Date
December 15, 2021
Document Date
December 15, 2021
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Aerovate Therapeutics, Inc.
Issuer
Aerovate Therapeutics, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us
Aerovate Therapeutics
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us

© 2023 Aerovate Therapeutics, Inc. All Rights Reserved. | Privacy Policy | Terms of Use